FITBP
FIFTH THIRD BANCORP
$23.64
+0.49%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
Jun 10, 2026
SEC
Fifth Third Bancorp completed an exchange offer on June 10, 2026, issuing up to $334.65 million of 4.000% Senior Notes d
8-K — Impact 3/10
May 22, 2026
SEC
Fifth Third Bancorp announced early tender results for its exchange offers to swap up to $1.55 billion of Comerica-issue
8-K — Impact 3/10
May 8, 2026
SEC
Fifth Third Bancorp commenced private exchange offers to swap up to $1.55 billion aggregate principal amount of existing
8-K — Impact 3/10
Analyst Ratings
7Strong Buy
13Buy
7Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
3/10
Fifth Third Bancorp completed an exchange offer on June 10, 2026, issuing up to $334.65 million of 4.000% Senior Notes d
Jun 10, 2026
NEUTRAL
8-K
3/10
Fifth Third Bancorp announced early tender results for its exchange offers to swap up to $1.55 billion of Comerica-issue
May 22, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 3.0/10.
NEUTRAL
8-K
3/10
Fifth Third Bancorp completed an exchange offer on June 10, 2026, issuing up to $334.65 million of 4
Jun 10, 2026
NEUTRAL
8-K
3/10
Fifth Third Bancorp announced early tender results for its exchange offers to swap up to $1.55 billi
May 22, 2026
NEUTRAL
8-K
3/10
Fifth Third Bancorp commenced private exchange offers to swap up to $1.55 billion aggregate principa
May 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 74% buy across 27 analysts — 7 strong buy, 13 buy, 7 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $3.3B | 44.9% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $3.3B | 44.9% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $12.9B | 42.3% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $13.9B | 7.8% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 7 | 13 | 7 | 0 | 0 | 74% | |
| May 1, 2026 | 7 | 14 | 7 | 0 | 0 | 75% | |
| Apr 1, 2026 | 8 | 14 | 7 | 0 | 0 | 76% | |
| Mar 1, 2026 | 8 | 13 | 7 | 0 | 0 | 75% | |
| Feb 1, 2026 | 9 | 12 | 7 | 0 | 0 | 75% | |
| Jan 1, 2026 | 9 | 11 | 8 | 0 | 0 | 71% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.